Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
368,000
USD
|
627,000
USD
|
| Adjustments for increase (decrease) in trade and other payables |
8,058,000
USD
|
135,000
USD
|
| Adjustments for decrease (increase) in other current assets |
24,000
USD
|
459,000
USD
|
| Adjustments for decrease (increase) in biological assets |
8,083,000
USD
|
18,943,000
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
1,178,000
USD
|
1,639,000
USD
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
1,429,000
USD
|
9,478,000
USD
|